Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-05-15-Speech-3-088"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2002-05-15"^^xsd:date2
dcterms:Is Part Of	lp_eu:Vote (continuation)2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20020515.5.3-088"2
lpv:hasSubsequent	lp_eu:2002-05-15-Speech-3-0892
lpv:speaker	lp:Françoise Grossetête2
lpv:spokenAs	vice-chair; EPP-ED (2002-03-08--2004-07-19)3 member; Temporary committee on foot and mouth disease (2002-01-17--2002-12-17)3 member; Delegation to the EU-Cyprus Joint Parliamentary Committee (2002-03-07--2004-04-30)3 member; Committee on the Environment, Public Health and Consumer Policy (2002-01-17--2004-07-19)3 unknown; Démocratie libérale (1999-07-20--2002-11-17)3
lpv:translated text	". I have been a long-standing supporter of European research efforts. Problems related to research on stem cells and supernumerary embryos must not be tackled in emotional or simplistic terms. Given the fundamental, high principles and the universal values that we defend, it is our duty to completely rule out the risks of eugenics as well as cloning for reproductive purposes. We must not hide the fact that many people who are ill are waiting for new therapies to be developed that will offer many of them the possibility of recovery. Although the legislator’s task may be to provide a framework for research, the risk is that it will be bound up in an overly restrictive straitjacket. We must also encourage a Europe of discovery. Research also affects the daily lives of all European citizens and priority areas such as food safety, the fight against major diseases and the improvement of public health demonstrate the desire to associate research and well-being. I am also pleased to note the support for developing research into rare illnesses."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph